Tuesday, November 27, 2012

• Why Cash Overrules The Momentary Market Bounceat Seeking Alpha (Tue, Nov 27)

Friday, November 23, 2012

• Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developmentsat Seeking Alpha (Fri, Nov 23)
• FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011Marketwired (Fri, Nov 23)

Wednesday, November 21, 2012

• Why I'm 'In Cash' For Biotechs In A Bearish Marketat Seeking Alpha (Wed, Nov 21)
• Coventry’s Special Shareholder Meeting, Shire Partners with Boston Hospital: Healthcare Business Wrapat Wall St. Cheat Sheet (Wed, Nov 21)

Friday, November 9, 2012

• ASTEX PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 9)

Tuesday, October 30, 2012

• Astex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Oct 30)
• ASTEX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online (Tue, Oct 30)

Monday, October 29, 2012

• Astex Pharmaceuticals Inc Stock Downgraded (ASTX)at TheStreet (Mon, Oct 29)

Thursday, October 25, 2012

• Out Of The Red And Into The Black: John McCamant On Investment In Blood Cancer Companiesat Seeking Alpha (Thu, Oct 25)

Wednesday, October 24, 2012

• Astex Pharmaceuticals initiates AT13387 Phase 2 studytheflyonthewall.com (Wed, Oct 24)

Friday, October 12, 2012

• Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint VenturesMarketwired (Fri, Oct 12)

Thursday, October 11, 2012

• Astex Pharmaceuticals Inc Stock Upgraded (ASTX)at TheStreet (Thu, Oct 11)

Tuesday, October 9, 2012

• 4 Undervalued Cash-Heavy Stocks With Room To Run Higherat Seeking Alpha (Tue, Oct 9)

Friday, September 28, 2012

• Healthcare Business Update: Astex Sees EU Okay, Pozen Prevails In Court Rulingat Wall St. Cheat Sheet (Fri, Sep 28)
• ASTEX PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Sep 28)
• J&J gets new European approvals for cancer drugsAP (Fri, Sep 28)
• 5 Low Risk, High Reward Biotech Stocksat Motley Fool (Fri, Sep 28)

Tuesday, September 25, 2012

• 1 Pharma That's Failing Forwardat Motley Fool (Tue, Sep 25)

Monday, September 24, 2012

• ASTEX PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Sep 24)

Friday, September 21, 2012

• Healthcare Business Roundup: Astex Abandons Cancer Drug, LabCorp Sues VAat Wall St. Cheat Sheet (Fri, Sep 21)
• Biotech/Pharmaceutical News: 10 Pharmas Sidestep Procedures to Quicken Drug Developmentat Minyanville (Fri, Sep 21)
• Must Read: 3 Biotechs Rocking Today's Marketat Motley Fool (Fri, Sep 21)
• Astex stops developing possible cancer treatmentAP (Fri, Sep 21)
• Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012Marketwired (Fri, Sep 21)

Add ASTX News to My Yahoo!